Defective natural immunity: an early manifestation of human immunodeficiency virus infection.
Defective natural immunity: an early manifestation of human immunodeficiency virus infection.
复制标题
DOI:
10.1084/jem.182.3.789
复制
发表时间:
1995-09-01
影响因子:
15.3
通讯作者:
Pedersen, Bente Klarlund
中科院分区:
文献类型:
--
作者:
Ullum, Henrik;Gotzsche, Peter C.;Victor, Jette;Dickmeiss, Ebbe;Skinhoj, Peter;Pedersen, Bente Klarlund
Cytotoxicity mediated by natural killer (NK) and lymphokine-activated killer (LAK) cells may be of significance in host defense against viral infections. This study included 347 patients infected with human immunodeficiency syndrome virus (HIV) type 1 and 110 controls. The NK cell activity, either unstimulated or stimulated with interferon-alpha (IFN-alpha) or interleukin-2 (IL-2), and the LAK cell activity were suppressed in patients, but the NK/LAK cell activity did not differ between patients with AIDS and patients without AIDS. However, the IFN- alpha-stimulated NK cell activity and LAK cell activity were reduced in patients with symptoms of HIV disease (CDCIV) when compared with asymptomatic patients (CDCII+III). When the data were analyzed by multiple linear regression, the percentage of CD4+ cells had a positive effect on these two parameters in patients without AIDS, whereas the percentage of CD4+ cells had no significant effect on unstimulated and IL-2-stimulated NK cell activity in these patients. In controls and AIDS patients, the percentage of CD4+ cells had no effect on NK/LAK cell activity in multiple linear models. The total number of CD16+ cells was low in patients compared to controls, whereas the percentages of CD16+, CD56+, and CD16+CD56+ were either normal or elevated. Therefore, the decrease in NK cell subpopulations did not contribute to the observed depression in NK/LAK cell activity in vitro. It is concluded that natural immunity is suppressed in HIV-seropositive patients primarily because of a qualitative defect of the NK/LAK cells. This qualitative defect includes a reduced responsiveness to IFN-alpha, which is progressive until the onset of symptoms, and possibly related to the loss of CD4+ cells.
登录
查看更多内容
影响因子:
56.9
作者:
FAUCI, AS
通讯作者:
FAUCI, AS
影响因子:
3.8
作者:
GRYLLIS, C;WAINBERG, MA;BRENNER, B
通讯作者:
BRENNER, B
影响因子:
9.1
作者:
PLAEGERMARSHALL, S;SPINA, CA;BEALL, G
通讯作者:
BEALL, G
DOI:
10.1016/0167-5699(90)90070-p
发表时间:
1990-05-01
期刊:
IMMUNOLOGY TODAY
影响因子:
--
作者:
ROSENBERG, ZF;FAUCI, AS
通讯作者:
FAUCI, AS
影响因子:
5.4
作者:
CHEHIMI, J;BANDYOPADHYAY, S;STARR, SE
通讯作者:
STARR, SE